ACRV Acrivon Therapeutics, Inc.

Fundamentals / CIK 0001781174 / USD

Acrivon Therapeutics, Inc. reported $85.75M in total assets and a net loss of $73.89M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ACRV in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$0$0$0-$75.32MFY 2021 Net Income: -$16.24M2021FY 2022 Net Income: -$31.17M2022FY 2023 Net Income: -$60.39M2023FY 2024 Net Income: -$80.56M2024FY 2025 Net Income: -$77.91M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $59.99M $63.99M $46.02M $23.95M --
Total Operating Expenses $84.11M $89.20M $67.10M $32.66M $16.18M
Operating Income -$84.11M -$89.20M -$67.10M -$32.66M -$16.18M
EBITDA -$82.76M -$88.19M -$66.57M -$32.29M -$16.15M
Interest Income -- -- $7.00M $1.50M --
Income Before Tax -$77.83M -$80.44M -- -- --
Income Tax Expense $0 -- -- -- --
Net Income -$77.91M -$80.56M -$60.39M -$31.17M -$16.24M
Basic EPS -$2.02 -$2.38 -$2.74 -$7.56 -$9.32
Diluted EPS -$2.02 -$2.38 -$2.74 -$7.56 -$9.32
Basic Shares Outstanding 38.5M 33.8M 22.1M 4.1M 1.7M
Diluted Shares Outstanding 38.5M 33.8M 22.1M 4.1M 1.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $14.55M $13.84M $15.17M $14.75M $13.65M $16.18M $15.41M $18.63M
Total Operating Expenses $18.52M $18.67M $19.90M $20.12M $19.69M $22.65M $21.66M $24.95M
Operating Income -$18.52M -$18.67M -$19.90M -$20.12M -$19.69M -$22.65M -$21.66M -$24.95M
EBITDA -$18.12M -$18.27M -$19.52M -$19.75M -$19.39M -$22.35M -$21.35M -$24.65M
Net Income -$17.90M -$17.96M -$19.04M -$18.98M -$18.23M -$21.01M -$19.68M -$22.83M
Basic EPS -$0.42 -$0.43 -$0.49 -- -$0.47 -$0.55 -$0.51 --
Diluted EPS -$0.42 -$0.43 -$0.49 -- -$0.47 -$0.55 -$0.51 --
Basic Shares Outstanding 42.9M 41.8M 38.7M -- 38.6M 38.5M 38.4M --
Diluted Shares Outstanding 42.9M 41.8M 38.7M -- 38.6M 38.5M 38.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $41.50M $39.82M $36.02M $29.52M $99.60M
Short-Term Investments $77.08M $139.7M $91.44M $98.23M --
Cash & Short-Term Investments $118.6M $179.5M $127.5M $127.8M $99.60M
Total Current Assets $120.4M $181.6M $129.7M $132.1M $100.4M
Property, Plant & Equipment, Net $4.89M $4.47M $3.48M $2.09M $290K
Long-Term Investments -- $5.09M -- $41.88M --
Other Non-Current Assets $1.65M $1.65M $251K -- --
Total Non-Current Assets $9.27M $14.96M $8.57M $49.13M $6.18M
Total Assets $129.7M $196.6M $138.3M $181.2M $106.6M
Accounts Payable $2.28M $758K $5.05M $904K $964K
Total Current Liabilities $15.66M $17.21M $13.30M $6.52M $2.91M
Total Non-Current Liabilities $1.54M $2.59M $3.77M $4.24M $4.96M
Total Liabilities $17.20M $19.80M $17.07M $10.75M $7.88M
Total Debt (incl. Leases) $2.71M $3.65M $4.64M $4.96M $5.63M
Common Stock $31K $31K $23K $22K $2.0K
Retained Earnings -$274.9M -$197.0M -$116.4M -$56.03M -$24.86M
Accumulated Other Comp. Income $111K $447K -$83K -$95K --
Total Stockholders' Equity $112.5M $176.8M $121.2M $170.5M -$23.81M
Total Equity $112.5M $176.8M $121.2M $170.5M -$23.81M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $47.53M $41.42M $34.06M $41.50M $35.41M $41.90M $39.15M $39.82M
Short-Term Investments $30.22M $48.54M $63.67M $77.08M $93.85M $95.53M $110.5M $139.7M
Cash & Short-Term Investments $77.75M $89.96M $97.74M $118.6M $129.3M $137.4M $149.6M $179.5M
Total Current Assets $79.08M $91.49M $99.22M $120.4M $130.4M $138.4M $151.3M $181.6M
Property, Plant & Equipment, Net $3.83M $4.25M $4.65M $4.89M $5.19M $5.07M $4.68M $4.47M
Long-Term Investments -- -- -- -- $5.11M $10.20M $15.20M $5.09M
Other Non-Current Assets $945K $1.18M $1.51M $1.65M $1.65M $1.65M $1.65M $1.65M
Total Non-Current Assets $6.67M $7.60M $8.61M $9.27M $14.94M $20.17M $25.02M $14.96M
Total Assets $85.75M $99.09M $107.8M $129.7M $145.3M $158.6M $176.3M $196.6M
Accounts Payable $616K $861K $1.16M $2.28M $996K $1.16M $3.69M $758K
Total Current Liabilities $14.28M $11.45M $11.05M $15.66M $14.89M $13.43M $13.55M $17.21M
Total Non-Current Liabilities $693K $980K $1.26M $1.54M $1.80M $2.12M $2.41M $2.59M
Total Liabilities $14.97M $12.43M $12.32M $17.20M $16.70M $15.55M $15.96M $19.80M
Total Debt (incl. Leases) $1.80M $2.12M $2.42M $2.71M $2.99M $3.26M $3.51M $3.65M
Common Stock $42K $42K $38K $31K $31K $31K $31K $31K
Retained Earnings -$329.8M -$311.9M -$293.9M -$274.9M -$255.9M -$237.7M -$216.7M -$197.0M
Accumulated Other Comp. Income -$26K -$33K $4.0K $111K $112K $106K $283K $447K
Total Stockholders' Equity $70.77M $86.67M $95.52M $112.5M $128.6M $143.0M $160.4M $176.8M
Total Equity $70.77M $86.67M $95.52M $112.5M $128.6M $143.0M $160.4M $176.8M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$77.91M -$80.56M -$60.39M -$31.17M -$16.24M
Depreciation & Amortization $1.36M $1.01M $536K $364K $37K
Stock-Based Compensation $14.72M $14.29M $11.62M $2.19M $497K
Change in Payables $1.54M -$3.59M $3.61M -$245K $798K
Operating Cash Flow -$63.66M -$65.67M -$42.64M -$30.12M -$13.98M
Capital Expenditure -$1.67M -$2.77M -$1.29M -$2.17M -$238K
Free Cash Flow -$65.33M -$68.44M -$43.93M -$32.28M -$14.22M
Purchases of Investments -$81.73M -$202.9M -$56.53M -$150.2M --
Investing Cash Flow $66.10M -$51.77M $50.72M -$141.7M -$238K
Financing Cash Flow -$749K $121.0M -$1.55M $101.7M $112.2M
Net Change in Cash $1.69M $3.59M $6.52M -$70.08M $98.00M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$17.90M -$17.96M -$19.04M -$18.98M -$18.23M -$21.01M -$19.68M -$22.83M
Depreciation & Amortization $400K $400K $383K $361K $300K $300K $311K $303K
Stock-Based Compensation $2.00M $2.21M $2.18M $3.09M $3.91M $3.93M $3.79M $3.71M
Change in Payables -$245K -$214K -$1.20M $1.28M -$9.0K -$2.55M $2.82M -$231K
Operating Cash Flow -$12.38M -$14.86M -$20.54M -$15.24M -$12.28M -$16.61M -$19.54M -$17.36M
Capital Expenditure $0 -$87K -$14K -$219K -$899K -$493K -$58K -$827K
Free Cash Flow -$12.38M -$14.95M -$20.55M -$15.46M -$13.18M -$17.10M -$19.59M -$18.19M
Purchases of Investments $0 -$9.97M -$16.86M -$13.26M -$33.19M -$15.06M -$20.23M -$34.76M
Investing Cash Flow $18.50M $14.95M $13.13M $21.52M $5.91M $19.45M $19.21M $14.41M
Financing Cash Flow $0 $7.27M -$33K -$192K -$117K -$97K -$343K -$647K
Net Change in Cash $6.12M $7.35M -$7.44M $6.09M -$6.49M $2.74M -$664K -$3.60M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -69.2% -45.6% -49.8% -18.3% --
Return on Assets (ROA) -60.1% -41.0% -43.7% -17.2% -15.2%
Current Ratio 7.69x 10.55x 9.75x 20.27x 34.46x
Quick Ratio 7.57x 10.43x 9.58x 19.61x 34.18x
Debt to Equity 0.02x 0.02x 0.04x 0.03x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -104.4% -85.6% -80.9% -69.2% -63.6% -60.1% -52.2% -45.6%
Return on Assets (ROA) -86.2% -74.9% -71.7% -60.1% -56.3% -54.2% -47.5% -41.0%
Current Ratio 5.54x 7.99x 8.98x 7.69x 8.75x 10.31x 11.17x 10.55x
Quick Ratio 5.44x 7.86x 8.84x 7.57x 8.68x 10.23x 11.04x 10.43x
Debt to Equity 0.03x 0.02x 0.03x 0.02x 0.02x 0.02x 0.02x 0.02x
Source: SEC EDGAR CompanyFacts (CIK 0001781174) · from March 31, 2021 Data through September 30, 2026 · synced Nov 20, 2026, 05:51 UTC · Open in terminal